Volatile Week, but Green? Click to watch the new Podcast.

$22.27 (3.25%)

Volume: 2.886M

Closed: Jul 05, 2022

Hollow Logo Score: 2.229

Exelixis Stock Forecast

BUY SELL NASDAQ:EXEL
$22.27 (3.25%)

Volume: 2.886M

Closed: Jul 05, 2022

Score Hollow Logo 2.229

EXEL Price Targets and Analyst Ratings NASDAQ:EXEL

Historical Ratings and Targets

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-06-24 25.73% BMO Capital $28.00 Initiates Coverage On Outperform
2022-02-18 88.59% HC Wainwright & Co. $52.00 $42.00 Maintains Buy
2021-11-03 39.2% RBC Capital $32.00 $31.00 Maintains Outperform
2021-11-03 133.5% HC Wainwright & Co. $65.00 $52.00 Maintains Buy
2021-11-02 30.22% Oppenheimer $30.00 $29.00 Maintains Outperform
2021-10-07 25.73% Jefferies $28.00 Initiates Coverage On Buy
2021-09-20 61.65% Truist Securities $37.00 $36.00 Maintains Buy
2021-06-28 34.71% Needham $33.00 $30.00 Maintains Buy
2021-06-15 111.05% HC Wainwright & Co. $47.00 Initiates Coverage On Buy
2021-04-19 16.75% Morgan Stanley $27.00 $26.00 Maintains Equal-Weight
2021-03-31 34.71% Credit Suisse $30.00 Initiates Coverage On Outperform
2021-03-12 57.16% Wolfe Research $35.00 Initiates Coverage On Outperform
2021-02-16 61.65% Piper Sandler $33.00 $36.00 Maintains Overweight
2020-12-16 21.24% Morgan Stanley $29.00 $27.00 Maintains Equal-Weight
2020-10-26 21.24% Stifel $26.00 $27.00 Maintains Hold
2020-09-22 30.22% Morgan Stanley $23.00 $29.00 Maintains Equal-Weight
2020-09-21 66.14% Oppenheimer $33.00 $37.00 Maintains Outperform
2020-09-21 48.18% Piper Sandler $30.00 $33.00 Maintains Overweight
2020-08-07 3.28% Morgan Stanley $22.00 $23.00 Maintains Equal-Weight
2020-07-15 -1.21% Morgan Stanley $21.00 $22.00 Maintains Equal-Weight
2020-06-01 43.69% Oppenheimer $28.00 $32.00 Maintains Outperform
2020-05-14 79.61% SunTrust Robinson Humphrey $35.00 $40.00 Maintains Buy
2020-05-06 21.24% BMO Capital $20.00 $27.00 Maintains Market Perform
2020-05-06 -5.7% Morgan Stanley $20.00 $21.00 Maintains Equal-Weight
2020-04-21 25.73% Oppenheimer $25.00 $28.00 Maintains Outperform
2020-04-20 48.18% Needham $28.00 $33.00 Maintains Buy
2020-03-04 16.75% Barclays $26.00 Initiates Coverage On Overweight
2020-02-26 3.28% Stifel $21.00 $23.00 Maintains Hold
2020-02-26 -10.19% BMO Capital $19.00 $20.00 Maintains Market Perform
2020-01-13 39.2% SunTrust Robinson Humphrey $31.00 Initiates Coverage On Buy
2020-01-13 -5.7% B of A Securities $22.00 $21.00 Reiterates Buy
2019-10-15 12.26% Guggenheim $33.00 $25.00 Maintains Buy
2019-10-08 -14.68% BMO Capital $23.00 $19.00 Maintains Market Perform
2019-08-01 3.28% Stifel $22.00 $23.00 Maintains Hold

EXEL Stock Trend

Given the current short-term trend, the stock is expected to fall -14.53% during the next 3 months and, with a 90% probability hold a price between $13.29 and $19.03 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-07-07 $15.48 $18.85 $22.21
2022-07-08 $15.42 $18.78 $22.14
2022-07-11 $15.36 $18.72 $22.08
2022-07-12 $15.29 $18.66 $22.02
2022-07-13 $15.23 $18.59 $21.95
2022-07-14 $15.17 $18.53 $21.89
2022-07-15 $15.11 $18.47 $21.83
2022-07-18 $15.04 $18.40 $21.77
2022-07-19 $14.98 $18.34 $21.70
2022-07-20 $14.92 $18.28 $21.64
2022-07-21 $14.85 $18.21 $21.58
2022-07-22 $14.79 $18.15 $21.51
2022-07-25 $14.73 $18.09 $21.45
2022-07-26 $14.66 $18.03 $21.39
2022-07-27 $14.60 $17.96 $21.32
2022-07-28 $14.54 $17.90 $21.26
2022-07-29 $14.47 $17.84 $21.20
2022-08-01 $14.41 $17.77 $21.13
2022-08-02 $14.35 $17.71 $21.07
2022-08-03 $14.28 $17.65 $21.01
2022-08-04 $14.22 $17.58 $20.94
2022-08-05 $14.16 $17.52 $20.88
2022-08-08 $14.10 $17.46 $20.82
2022-08-09 $14.03 $17.39 $20.76
2022-08-10 $13.97 $17.33 $20.69
2022-08-11 $13.91 $17.27 $20.63
2022-08-12 $13.84 $17.20 $20.57
2022-08-15 $13.78 $17.14 $20.50
2022-08-16 $13.72 $17.08 $20.44
2022-08-17 $13.65 $17.02 $20.38

IMPROVE YOUR TRADING GAME WITH A GOLDEN STAR

From 26 533 stocks, only a few dozen will trigger such a signal!

About Exelixis

Exelixis Exelixis, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of new medicines with the potential to enhance care and outcomes for people with cancer. It focuses on advancing cabozantinib, an inhibitor of multiple tyrosine kinases, including MET, AXL, and VEGF receptors, which has shown clinical anti-tumor activity in approximately 20 forms of cancer and is the subject of a broad clinical development pr... Read more

.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT